Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 28(36): 3246-60, 2009 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-19597466

RESUMO

Lithium has long been used for the treatment and prophylaxis of bipolar mood disorder. However, nerve cells are not the sole targets of lithium. Indeed, lithium was reported to target numerous cell types, and affect cell proliferation, differentiation and death. Thus, the idea has been raised that lithium may act on signaling pathways involved in neoplastic transformation. Indeed, the effect of lithium on tumor progression is currently being tested in a limited number of clinical trials. However, the molecular mechanisms by which lithium affects neoplastic transformation remain to be characterized. Here, using mouse fibroblasts transformed by the v-src oncogene as a model, we show that lithium drastically inhibits cell motility and compromises the invasive phenotype of v-src-transformed cells. In addition, we show that this effect is mediated by the activation of phosphotyrosine phosphatases, but not by the direct inhibition of the v-Src tyrosine kinase. Finally, we show that lithium activates phosphotyrosine phosphatases by the modulation of the redox status of the cell, independently of the Wnt and the inositol phosphate canonical pathways. Thus, this study supports the idea that lithium, acting similar to an antioxydizer, may have antimetastatic properties in vivo.


Assuntos
Movimento Celular/efeitos dos fármacos , Glutationa/metabolismo , Compostos de Lítio/farmacologia , Proteínas Tirosina Fosfatases/metabolismo , Animais , Western Blotting , Proliferação de Células/efeitos dos fármacos , Transformação Celular Viral , Embrião de Galinha , Membrana Corioalantoide/patologia , Relação Dose-Resposta a Droga , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Cloreto de Lítio/farmacologia , Metaloproteinase 2 da Matriz/metabolismo , Camundongos , Microscopia de Fluorescência , Células NIH 3T3 , Neoplasias Experimentais/patologia , Ácido Okadáico/farmacologia , Proteína Oncogênica pp60(v-src)/genética , Proteína Oncogênica pp60(v-src)/metabolismo , Fosforilação/efeitos dos fármacos , Proteínas Tirosina Fosfatases/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , Vanadatos/farmacologia
2.
Biomaterials ; 28(12): 2155-62, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17258312

RESUMO

Osteoclast activity was studied on nacre, the mother of pearl (MOP) in order to assess the plasticity of bone resorbing cells and their capacity to adapt to a biomineralized material with a different organic and mineral composition from that of its natural substrate, bone. Pure MOP, a natural biomineralized CaCO(3) material, was obtained from Pinctada oyster shell. When implanted in the living system, nacre has proven to be a sustainable bone grafting material although a limited surface degradation process. Osteoclast stem cells and mature osteoclasts were cultured on MOP substrate and osteoclast precursor cells were shown to differentiate into osteoclasts capable of resorbing nacre substrate. However, analysis of the organization of the cytoskeleton showed that both a sealing zone and a podosome structure were observed on the nacre substrate. Moreover, MOP resorption efficiency was consistently found to be lower than that of bone and appeared to be a limited process.


Assuntos
Carbonato de Cálcio/química , Osteoclastos/citologia , Animais , Adesão Celular , Células Cultivadas , Citoesqueleto/ultraestrutura , Humanos , Microscopia Eletrônica de Varredura , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...